Tokin, a Russian biochemist, are antimicrobial allelochemic volatile organic compounds emitted by plants to defend against decay or attack by herbivores
Mycotoxin screening methods can be enhanced by improving sensitivity, simplicity, robustness, and reusability
So I think it is very, very promising, but I would not, as an oncologist, consider the data at this point definitive
What works for one person, even a public figure, may not be effective or safe for another
The single most significant near-term opportunity is the genericization wave anticipated between 2026 and 2030, during which time the progressive expiry of Novo Nordisk's semaglutide patent portfolio across major markets will enable dozens of generic pharmaceutical companies to enter the semaglutide formulation market, each requiring third-party API supply
Sarah Morgan Yeah